Market Intelligence Resource | December 10, 2010

North Carolina DHHS Proposed Prior Authorization for Off-Label Antipsychotic Safety Monitoring in Children to Age 18

December 10, 2010 The North Carolina Division of Medical Assistance (DMA) released a draft policy updating safety monitoring requirements and documentation needed for children up to age 18 who are prescribed antipsychotic medications. The monitoring focuses on metabolic and neurological side effects related to Haloperidol, Aripiprazole, Olanzapine IR, Risperidone, Quetiapine, and Pimozide. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.